Sort by
Keyphrases
Adrenocortical Carcinoma
77%
Adrenocortical Carcinoma Cells
20%
Anticancer Activity
23%
Antiproliferative Activity
64%
Apoptosis
21%
Cancer Cell Lines
18%
Chemotherapy
22%
Cisplatin
79%
Client Proteins
18%
Combination Therapy
24%
Cytotoxicity
30%
Dose Effect
17%
Entrepreneurship
21%
Head-and-neck
19%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
54%
Heat Shock Protein 90 (Hsp90)
84%
Heat Shock Protein 90 Inhibitor
37%
Heat Shock Response
26%
Hsp90 Inhibitor
78%
Hyaluronan
43%
In Cancer
31%
Induced Apoptosis
61%
Intralymphatic
26%
Long Non-coding RNA (LncRNA)
19%
Lymphatic System
25%
Lymphatics
42%
Malignancy
21%
Medullary Thyroid Carcinoma
29%
Melanoma
55%
Metastatic Melanoma
33%
Mitogen-activated Protein Kinase
23%
Nanoconjugates
32%
Nanoparticles
25%
Novel Therapeutics
18%
Novobiocin
26%
Overall Survival
20%
Parathyroid Hormone Levels
20%
Parathyroidectomy
28%
Phosphorylation
19%
Physalis
18%
Physalis Longifolia
37%
Primary Hyperparathyroidism (pHPT)
43%
Synthetic High-density Lipoprotein
33%
Terminal Heat
19%
Thyroid Cancer
32%
Triacetate
27%
Tumor
44%
Western Blot Analysis
20%
Withaferin A
95%
Withanolides
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenal Cortex Carcinoma
67%
Antiproliferative Activity
37%
Breast Cancer
52%
Carboxamide
19%
Cell Viability
14%
Chaperone
16%
Chemotherapy
40%
Cisplatin
79%
Clinical Trial
18%
Combination Therapy
24%
Cytotoxicity
34%
Deferoxamine
16%
Differentiated Thyroid Cancer
14%
Diseases
50%
Doxorubicin
22%
Glioblastoma
18%
Head and Neck Squamous Cell Carcinoma
54%
Heat Shock Protein 90
21%
Heat Shock Protein 90 Inhibitor
57%
High Density Lipoprotein
33%
Hyaluronic Acid
44%
IC50
37%
Lactone
16%
Malignant Neoplasm
98%
Melanoma
51%
Metastatic Melanoma
16%
Mitogen Activated Protein Kinase Kinase Inhibitor
16%
Nanocarrier
22%
Nanoconjugate
19%
Nanoparticle
25%
Natural Product
17%
Neoplasm
54%
Neuroblastoma
16%
Novobiocin
16%
Parathyroid Hormone
16%
Phosphotransferase
14%
Physalis
39%
Protein Tyrosine Kinase
14%
Recurrent Disease
13%
Sorafenib
16%
Squamous Cell Carcinoma
24%
Structure Activity Relationship
25%
Tanespimycin
16%
Thyroid Cancer
65%
Thyroid Medullary Carcinoma
21%
Triple Negative Breast Cancer
20%
Vemurafenib
13%
Western Blot
28%
Withaferin A
86%
Withanolide
93%
Medicine and Dentistry
Adrenal Cortex Carcinoma
42%
Breast Cancer
17%
Breast Reconstruction
16%
Cancer
35%
Cancer Cell
22%
Cancer Stem Cell
21%
Carboxy Terminal Sequence
29%
Cell Cycle
16%
Cisplatin
26%
Conjugate
18%
Deferoxamine
16%
Diseases
53%
Fine-Needle Aspiration
19%
Fluorodeoxyglucose
14%
General Surgery
15%
Head and Neck Squamous Cell Carcinoma
29%
Hepatocellular Carcinoma
19%
Hormone Determination
18%
Hsp90 Inhibitor
34%
IC50
21%
In Vitro
38%
Isotopes of Calcium
19%
Lymph Duct
38%
Lymphatic System
21%
Malignant Neoplasm
31%
Melanoma
81%
Metastatic Carcinoma
33%
Metastatic Melanoma
22%
Neck
21%
Neoplasm
37%
Overall Survival
15%
Parathyroid
16%
Parathyroid Hormone
39%
Parathyroidectomy
43%
Patient Care
15%
Positron Emission Tomography
21%
Primary Hyperparathyroidism
43%
Programmed Cell Death
28%
Recurrent Disease
25%
Restylane
26%
Sentinel Lymph Node Biopsy
16%
Surgeon
34%
Targeted Therapy
19%
Thyroid Cancer
44%
Thyroid Medullary Carcinoma
21%
Thyroid Nodule
16%
Thyroidectomy
24%
Western Blot
15%
Withaferin A
28%
Withanolide
44%